Stephen Ting

11PUBLICATIONS
48CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 03, 2026
Role of FibroScan in evaluating hepatic involvement in systemic amyloidosis: a single-centre prospective pilot study.

|Mar 02, 2026
Thrombopoietin Receptor Agonists Plus Immunosuppressive Therapy in Aplastic Anaemia: A Systematic Review and Meta-Analysis.

Elham Ashrafi, Lauren Young, Lucy C Fox

|Feb 24, 2026
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

|Feb 22, 2026
An Australian Amyloidosis Network analysis of Australian patients with immunoglobulin light chain amyloidosis treated with bortezomib-based chemotherapy.

Anthea Gibbons, Lipi Chakravorty, Hasib Sidiqi

|Nov 21, 2025
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy.

Andrew H Wei, Panayiotis Panayiotidis, Pau Montesinos

|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

Pageof 2

Frequent Collaborators

6 joint publications

Andrew H Wei

5 joint publications

Ing Soo Tiong

4 joint publications

Pau Montesinos

2 joint publications

Achilles Anagnostopoulos